Lamisil

Terbinafine, the active ingredient in Lamisil, is a allylamine antifungal presented as a topical formulation for skin use. It is employed to treat superficial fungal infections of the skin and is indicated for use in adults and children when prescribed by a healthcare professional.

GNH USA supplies Lamisil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamisil is an allylamine antifungal used to treat infections caused by dermatophytes affecting the skin. - Tinea pedis: alleviates itching and clears fungal infection of the feet. - Tinea corporis: resolves ring‑shaped lesions on the body. - Tinea cruris: treats fungal infection of the groin area. - Superficial dermatophytosis: eliminates fungal growth on the skin surface.

Terbinafine may cause a range of skin‑related reactions.

Common Side Effects: - Itching: mild to moderate discomfort at the application site. - Redness: localized erythema. - Burning sensation: transient heat feeling. - Scaling: flaking of the treated skin. - Dryness: reduced skin moisture. - Irritation: mild stinging or discomfort.

Serious or Rare Side Effects: - Allergic reaction: hives, swelling, or rash. - Severe skin rash: extensive redness or blistering. - Swelling of face, lips, or tongue. - Difficulty breathing or wheezing. - Liver toxicity: jaundice or abnormal liver tests (rare).

Before using Lamisil, consider the following safety measures. - Assess liver function: ensure normal hepatic status prior to therapy. - Avoid broken skin: do not apply on open wounds or irritated areas. - Monitor for allergic reactions: discontinue if rash or swelling occurs. - Use only as prescribed: follow healthcare professional instructions. - Keep away from eyes: avoid contact with ocular surfaces. - Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Terbinafine can interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Cimetidine: may increase terbinafine plasma levels. - Ritonavir: can raise terbinafine concentrations, risking toxicity. - Nefazodone: may lead to elevated terbinafine exposure.

Moderate Interactions (Monitor Closely): - Warfarin: monitor INR for potential anticoagulant effect changes. - Oral contraceptives: efficacy may be reduced; consider alternative contraception. - Alcohol: increased risk of liver enzyme elevation. - Other antifungals: concurrent use may enhance side‑effect profile. - Antidiabetic agents: monitor blood glucose as terbinafine may affect metabolism.